RESEARCH-USE BIOSIMILAR ANTIBODY
Befovacimab
Monoclonal antibody · IgG2
Befovacimab (BAY 1093884) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitor (TFPI). Befovacimab can be used for haemophilia A/B research.
TARGETTFPI
YMonoclonal antibody
CATALOGSC-BS-741
CATALOG NUMBERSC-BS-741
MOLECULAR WEIGHTApprox. 142.98 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Befovacimab (BAY 1093884) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitor (TFPI). Befovacimab can be used for haemophilia A/B research.
Befovacimab is a recombinant research-use antibody directed against TFPI.